Milestone Scientific Inc. Reports Continued Development in Dental Product sales

ROSELAND, N.J., Nov. 30, 2020 (Globe NEWSWIRE) — Milestone Scientific Inc. (NYSE American:MLSS), a major developer of computerized drug shipping instruments that presents just about pain-free and precise injections, currently offered an update on the predicted growth in dental revenue throughout the fourth quarter of 2020.

Arjan Haverhals, President of Milestone Scientific and CEO of Wand Dental Inc., said, “As previously reported, our dental small business has ongoing to get well, as dental places of work reopen across the country and around the globe. Even though we are not back to pre-pandemic amounts, I am pleased to report our income go on trending in the right route and we foresee revenue in the fourth quarter of 2020 to be a minimal of $1.7 million. This would signify a 40{ceedb287d77e8cde5bf2878339831566d6a2b6f7559fed38ec8bb489262cb257} sequential improve vs . the third quarter, which follows the 718{ceedb287d77e8cde5bf2878339831566d6a2b6f7559fed38ec8bb489262cb257} boost for the third quarter of 2020 as opposed to the second quarter of 2020. This does not include recent revenue to our Chinese distributor of approximately $450,000, which we will only report as earnings when the stock is resold by our distributor. We are inspired by the present trends in each the Usa and all-around the environment, which has improved our cash move and supplies us larger financial balance alongside with the vital funds for promoting and profits to continue on the progress in the dental sector. At the same time, we go on to execute on our professional system all over the CompuFlo® Epidural System and CathCheck™.”

“We attribute the improvement in dental sales to our profitable income and internet marketing initiatives as a result of our direct efforts. Furthermore, we have terminated the special legal rights granted to Henry Schein for distribution of The Wand® STA instrument and disposables in the United states and Canada. As for every the arrangement, Henry Schein Inc. will keep on being a distributor, albeit on a non-unique basis. As a end result, we now search forward to utilizing a system the place we will have several distributors throughout the United States and Canada. We believe this will make it possible for us to increase our industry penetration, with a a lot more major return on our advertising dollars.”

“It is vital to reiterate that The Wand® STA instrument offers significant benefits in phrases of establishing a risk-free surroundings for patients and personnel through the pandemic, which has been reinforced primarily based on the suggestions we gained from dentists. Our improved advertising and marketing initiatives all over The Wand® STA instrument aim on the important benefit motorists of our instrument, together with protection, efficiency, and, importantly, supporting the advancement of dental procedures.”

About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a biomedical technological innovation exploration and enhancement corporation that patents, models and develops ground breaking diagnostic and therapeutic injection systems and instruments for medical, dental, beauty and veterinary applications. Milestone’s laptop or computer-controlled units are intended to make injections specific, effective, and pretty much pain-free. Milestone’s proprietary DPS Dynamic Pressure Sensing technology® is our technological innovation platform that innovations the growth of upcoming-era gadgets, regulating circulation charge and monitoring stress from the idea of the needle, via system extensions for area anesthesia for subcutaneous drug shipping and delivery, with particular purposes for cosmetic botulinum toxin injections, epidural room identification in regional anesthesia procedures and intra-articular joint injections. For much more information remember to check out our web site: www.milestonescientific.com.

Safe Harbor Assertion

This press launch is made up of ahead-on the lookout statements relating to the timing and economic effect of Milestone’s capability to apply its business enterprise plan, anticipated revenues, timing of regulatory approvals and long term accomplishment. These statements entail a number of threats and uncertainties and are primarily based on assumptions involving judgments with regard to upcoming financial, aggressive and market conditions, foreseeable future business enterprise choices and regulatory developments, all of which are complicated or not possible to predict accurately and a lot of of which are further than Milestone’s command. Some of the essential things that could cause real outcomes to vary materially from individuals indicated by the ahead-on the lookout statements are general financial circumstances, failure to achieve predicted revenue progress, changes in our operating fees, adverse patent rulings, Food and drug administration or authorized developments, aggressive pressures, alterations in buyer and market requirements and criteria, and the chance things in-depth from time to time in Milestone’s periodic filings with the Securities and Exchange Fee, which includes devoid of limitation, Milestone’s Once-a-year Report for the 12 months finished December 31, 2019. The forward-hunting statements in this press release are centered upon management’s sensible belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any ahead-wanting statements for any purpose.

Call:
David Waldman or Natalya Rudman
Crescendo Communications, LLC
E mail: [email protected]
Tel: 212-671-1020